• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

进行性特发性肺纤维化的联合治疗方法——吡非尼酮作为体外肺移植的桥接治疗:一例病例报告

A combined therapeutic approach in progressive idiopathic pulmonary fibrosis-pirfenidone as bridge therapy for ex vivo lung transplantation: a case report.

作者信息

Paone G, Sebastiani A, Ialleni E, Diso D, Rose D, Quagliarini F, Ialongo P, Peruzzi M, Venuta F, Frati G

机构信息

Department of Cardiovascular, Respiratory, Nephrologic, Anesthesiologic and Geriatric Sciences, Sapienza University of Rome, Rome, Italy; Department of Respiratory Diseases, S. Camillo-Forlanini Hospital, Rome, Italy.

Department of Respiratory Diseases, S. Camillo-Forlanini Hospital, Rome, Italy.

出版信息

Transplant Proc. 2015 Apr;47(3):855-7. doi: 10.1016/j.transproceed.2015.02.006.

DOI:10.1016/j.transproceed.2015.02.006
PMID:25891747
Abstract

Idiopathic pulmonary fibrosis (IPF) is a progressive fibrosing interstitial pneumonia of unknown etiology, which is associated with the histopathologic pattern of usual interstitial pneumonia (UIP) and leads to a progressive decrease of respiratory function. The present article describes a case of a 62-year-old ex-smoker referred to our hospital because of IPF. After 2 years of follow-up, the subject experienced a significant worsening of pulmonary function and was enrolled in a lung transplantation program. Afterward, a pharmacological treatment with pirfenidone was started, achieving a stabilization of respiratory function. The patient underwent a single lung transplantation by means of a normothermic ex vivo lung perfusion (EVLP) approach according to the Toronto model. At 20-month evaluation the subject's respiratory function was significantly improved, and quality of life was considerably ameliorated. We believe that an integrated multidisciplinary approach should be considered a key option for the treatment of individuals with IPF.

摘要

特发性肺纤维化(IPF)是一种病因不明的进行性纤维化间质性肺炎,与普通型间质性肺炎(UIP)的组织病理学模式相关,并导致呼吸功能逐渐下降。本文描述了一例62岁的戒烟者因IPF转诊至我院的病例。经过2年的随访,该患者的肺功能显著恶化,并被纳入肺移植项目。此后,开始使用吡非尼酮进行药物治疗,实现了呼吸功能的稳定。根据多伦多模式,该患者通过常温体外肺灌注(EVLP)方法接受了单肺移植。在20个月的评估中,患者的呼吸功能显著改善,生活质量也得到了大幅提高。我们认为,综合多学科方法应被视为治疗IPF患者的关键选择。

相似文献

1
A combined therapeutic approach in progressive idiopathic pulmonary fibrosis-pirfenidone as bridge therapy for ex vivo lung transplantation: a case report.进行性特发性肺纤维化的联合治疗方法——吡非尼酮作为体外肺移植的桥接治疗:一例病例报告
Transplant Proc. 2015 Apr;47(3):855-7. doi: 10.1016/j.transproceed.2015.02.006.
2
Pulmonary fibrolysis in a patient with idiopathic pulmonary fibrosis: improvement of clinical and radiological pattern after treatment with pirfenidone.一名特发性肺纤维化患者的肺纤维溶解:吡非尼酮治疗后临床和影像学表现的改善
Clin Respir J. 2018 Jan;12(1):347-351. doi: 10.1111/crj.12515. Epub 2016 Jul 7.
3
A multicentre retrospective observational study on Polish experience of pirfenidone therapy in patients with idiopathic pulmonary fibrosis: the PolExPIR study.波兰特发性肺纤维化患者吡非尼酮治疗的多中心回顾性观察研究:PolExPIR 研究。
BMC Pulm Med. 2020 May 4;20(1):122. doi: 10.1186/s12890-020-1162-6.
4
Pirfenidone Initiates a New Era in the Treatment of Idiopathic Pulmonary Fibrosis.吡非尼酮开创特发性肺纤维化治疗新纪元。
Annu Rev Med. 2016;67:487-95. doi: 10.1146/annurev-med-120214-013614. Epub 2015 Nov 4.
5
[Diagnostic criteria and possible treatment of idiopathic pulmonary fibrosis].[特发性肺纤维化的诊断标准及可能的治疗方法]
Ugeskr Laeger. 2014 Apr 28;176(18).
6
Pirfenidone for the treatment of idiopathic pulmonary fibrosis.吡非尼酮治疗特发性肺纤维化。
Expert Opin Pharmacother. 2014 Feb;15(2):275-81. doi: 10.1517/14656566.2014.867328. Epub 2013 Dec 6.
7
Safety and efficacy of pirfenidone in idiopathic pulmonary fibrosis in clinical practice.吡非尼酮治疗特发性肺纤维化的临床安全性和有效性。
Respir Med. 2013 Sep;107(9):1431-7. doi: 10.1016/j.rmed.2013.06.011. Epub 2013 Jul 9.
8
Current approaches to the management of idiopathic pulmonary fibrosis.特发性肺纤维化的当前管理方法。
Respir Med. 2017 Aug;129:24-30. doi: 10.1016/j.rmed.2017.05.017. Epub 2017 May 30.
9
Pirfenidone for the treatment of idiopathic pulmonary fibrosis.吡非尼酮用于治疗特发性肺纤维化。
Expert Rev Respir Med. 2014 Oct;8(5):539-45. doi: 10.1586/17476348.2014.915750. Epub 2014 Aug 12.
10
[Idiopathic pulmonary fibrosis: modern guideline-concordant diagnostics and innovative treatment].[特发性肺纤维化:符合现代指南的诊断与创新治疗]
Dtsch Med Wochenschr. 2012 Mar;137(12):601-4. doi: 10.1055/s-0031-1299003. Epub 2012 Mar 13.

引用本文的文献

1
Effect of pirfenidone on wound healing in lung transplant patients.吡非尼酮对肺移植患者伤口愈合的影响。
Multidiscip Respir Med. 2018 Jun 14;13:16. doi: 10.1186/s40248-018-0129-4. eCollection 2018.
2
Safety and efficacy of bridging to lung transplantation with antifibrotic drugs in idiopathic pulmonary fibrosis: a case series.特发性肺纤维化中使用抗纤维化药物过渡到肺移植的安全性和有效性:病例系列
BMC Pulm Med. 2016 Nov 18;16(1):156. doi: 10.1186/s12890-016-0308-z.